- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Merit Medical Systems Inc(MMSI)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for MMSI
11/13/2026: MMSI (2-star) is a SELL. SELL for 4 days. Simulated Profits (-3.70%). Updated daily EoD!
Merit Medical Systems is a global manufacturer of specialized medical devices, primarily serving the interventional cardiology, radiology, and oncology markets. The company has a leading position in niche product areas like inflation devices and benefits from a vertically integrated manufacturing model that supports consistent revenue growth. Its main growth story centers on expanding its clinical portfolio into high-growth therapeutic areas and improving operating margins. Key risks include intense pricing pressure from large, diversified medical device competitors and potential execution challenges related to its M&A-driven growth strategy. The stock may best suit growth-oriented investors looking for exposure to minimally invasive procedure trends while monitoring margin-improvement milestones.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Merit consistently seeks to expand its revenue base through a blend of product innovation and strategic market consolidation. |
| Momentum investor | Mixed fit | Momentum suitability is conditional on the stock maintaining a positive uptrend relative to medical device sector benchmarks. |
| Value investor | Mixed fit | Valuation is often tied to growth expectations, making the stock's attractiveness dependent on earnings multiple expansion. |
| Dividend investor | Weak fit | The company does not pay a cash dividend, focusing instead on reinvestment for capital growth. |
| Low-risk investor | Weak fit | As a small-to-mid-cap medical device firm, it is subject to higher volatility than diversified large-cap healthcare stocks. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | The stock can experience significant swings based on sector-wide healthcare news and acquisition news. |
| Valuation risk | Medium | Market pricing often assumes consistent double-digit growth, which poses a risk if expectations are missed. |
| Competition risk (Diversified device giants) | High | Large competitors like Abbott and Boston Scientific have greater scale to bundle products and pressure pricing. |
| Business quality | Medium | The company has strong niche franchises but lacks the massive scale of industry-leading diversified competitors. |
| Dividend income | Low / none | Merit provides no income return for investors relying on dividend yield. |
| Execution risk | Medium | Success depends on the ongoing ability to integrate acquisitions and maintain R&D output effectively. |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.19B USD | Price to earnings Ratio 32.45 | 1Y Target Price 107 |
Price to earnings Ratio 32.45 | 1Y Target Price 107 | ||
Volume (30-day avg) 724.2K shares | Beta 0.55 | 52 Weeks Range 59.74 - 94.85 | Updated Date 11/14/2026 |
52 Weeks Range 59.74 - 94.85 | Updated Date 11/14/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.67 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Instruments & Supplies
- BUY participation
- 60.0%
- Active BUY / eligible
- 3 / 5
- 30-Day BUY Count Change
- +1
Eligible universe: 5 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 23.04% | Avg. Invested days 46 | Today’s Advisory SELL |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Interventional Products | Inflation devices, catheters, and guidewires used in hospitals. | Most revenue comes from the daily recurring usage of disposable tools in life-saving vascular and cardiac procedures. |
| Geography (International) | Sales across Europe, Asia, and other regions. | Global diversification provides a hedge against domestic US hospital market fluctuations. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-10-29 | When After Market | Estimate 0.93 | Actual 1.01 |
Profitability
Profit Margin 9.94% | Operating Margin (TTM) 13.9% |
Management Effectiveness
Return on Assets (TTM) 5.04% | Return on Equity (TTM) 9.78% |
Valuation
Trailing PE 32.45 | Forward PE 18.55 | Enterprise Value 5.51B | Price to Sales(TTM) 3.22 |
Enterprise Value 5.51B | Price to Sales(TTM) 3.22 | ||
Enterprise Value to Revenue 3.42 | Enterprise Value to EBITDA 14.49 | Shares Outstanding 59.92M | Shares Floating 58.51M |
Shares Outstanding 59.92M | Shares Floating 58.51M | ||
Percent Insiders 2.44 | Percent Institutions 108.72 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

